August 12 Product: Ascendis Pharmas Yorvipath Indication: Hypoparathyroidism After a long regulatory road, Ascendis Pharma received FDA approval Monday for Yorvipath (TransCon PTH) for the treatment of hypoparathyroidism, a rare endocrine disease characterized by abnormally low levels of the parathyroid hormone
Weve shared seven important tips to help doctors and patients deal with the challenges of B12 treatment
Be aware that most of the TRIUMPH programme has now finished recruiting, and trials involve randomisation you may receive placebo
Storage Follow the vial's printed refrigeration and beyond-use instructions instead of assuming brand-pen rules apply
Book IV Therapy at Perfect B in Doral, FL Perfect B | 3905 NW 107th Ave, Suite 104, Doral FL 33178 Call or message us at (786) 502-2260 to schedule or ask which formulation fits your goal Vitamin C, B Complex, amino acids, minerals, glutathione, and biotin IV cocktails available standalone or combined with any treatment appointment Buy Now Pay Later: Cherry, Klarna, Afterpay, CareCredit